# Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain

> **NCT01961271** · PHASE4 · COMPLETED · sponsor: **Mundipharma Pte Ltd.** · enrollment: 114 (actual)

## Conditions studied

- Osteoarthritis
- Rheumatoid Arthritis
- Lower Back Pain
- Joint Pain
- Muscle Pain

## Interventions

- **DRUG:** Buprenorphine transdermal patch

## Key facts

- **NCT ID:** NCT01961271
- **Lead sponsor:** Mundipharma Pte Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2016-09-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01961271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01961271, "Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01961271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*